NASDAQ$CDLX
Cardlytics Inc · Q1 2022 earnings
Q1 2022 earnings · · Investor relations
Briefing
Cardlytics' Q1 2022 financial results were announced, revealing revenue above expectations and the largest Q1 ever.
Cardlytics reported a strong Q1 2022 with revenue of $67.9 million, a 28% increase year-over-year. The company achieved net income attributable to common stockholders of $33.0 million, or $0.91 per diluted share, compared to a net loss of $(24.9) million, or $(0.85) per diluted share in the first quarter of 2021.
- Revenue increased by 28% year-over-year to $67.9 million.
- Billings increased by 29% year-over-year to $98.2 million.
- Net income attributable to common stockholders was $33.0 million, or $0.91 per diluted share.
- Cardlytics MAUs increased by 6% year-over-year to 178.5 million and ARPU increased by 13% year-over-year to $0.36.
Headline financials
Revenue & EPS history
Cardlytics · Revenue · Quarterly
$67.9M
Forward guidance
Cardlytics anticipates billings to be between $106.0 million and $116.0 million, revenue to be between $73.0 million and $80.0 million, and adjusted contribution to be between $36.5 million and $40.5 million for the second quarter of 2022.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q1 2022
-6.1%
Avg return
Earnings day
-6.2%
Avg return
5 days after
+14.5%
Avg return
30 days after
47%
16 / 34 earnings
Positive
+68.6%
Q4 2023
Best reaction
-59.6%
Q2 2024
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | -2.0% | -15.0% | +654.7% | |
| Q4 2025 | -9.9% | -21.8% | +25.6% | |
| Q3 2025 | -28.5% | -16.5% | -37.5% | |
| Q1 2025 | -13.0% | -2.8% | -17.1% | |
| Q4 2024 | +4.5% | +18.7% | -25.3% | |
| Q3 2024 | -13.2% | -3.0% | -15.8% | |
| Q2 2024 | -59.6% | -51.9% | -53.1% | |
| Q1 2024 | -39.8% | -40.8% | -43.4% | |
| Q4 2023 | +68.6% | +64.0% | +57.8% | |
| Q3 2023 | -55.7% | -47.6% | -40.1% | |
| Q2 2023 | +15.7% | +21.2% | +42.8% | |
| Q1 2023 | -26.0% | -29.4% | -29.9% | |
| Q4 2022 | -10.8% | -9.4% | -37.7% | |
| Q3 2022 | -52.2% | -51.2% | -52.9% | |
| Q2 2022 | +18.3% | +10.6% | -7.6% | |
| Q1 2022 | +10.2% | -8.5% | -24.2% | |
| Q4 2021 | +5.7% | -7.1% | -5.2% | |
| Q3 2021 | +6.7% | +8.3% | -20.4% | |
| Q2 2021 | -32.5% | -29.2% | -22.3% | |
| Q1 2021 | -20.6% | -24.8% | -24.2% | |
| Q4 2020 | +1.2% | -3.3% | -17.2% | |
| Q3 2020 | +2.9% | +22.7% | +56.5% | |
| Q2 2020 | -9.1% | -8.9% | +0.8% | |
| Q1 2020 | +13.0% | +8.9% | +50.9% | |
| Q4 2019 | -36.4% | -43.7% | -64.3% | |
| Q3 2019 | +43.6% | +42.9% | +44.4% | |
| Q2 2019 | +20.0% | +24.1% | +39.8% | |
| Q1 2019 | +20.9% | +14.8% | +47.1% | |
| Q4 2018 | -5.6% | -11.7% | -7.2% | |
| Q3 2018 | -24.9% | -19.9% | -29.3% | |
| Q2 2018 | +0.3% | +3.0% | +27.3% | |
| Q2 2017 | +0.3% | +3.0% | +27.3% | |
| Q1 2018 | -1.0% | -7.4% | +6.5% | |
| Q4 2017 | +1.0% | +0.5% | -13.6% | |
| Q3 2017 | — | — | — | |
| Q1 2017 | — | — | — | |
| Q4 2016 | — | — | — | |
| Q3 2016 | — | — | — | |
| Q2 2016 | — | — | — | |
| Q1 2016 | — | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro